Ken Fisher’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Ken Fisher’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-99,189	Closed	-$662K	–	1148
2023 Q3	$662K	Hold	99,189	–	–	﹤0.01%	811
2023 Q2	$899K	Hold	99,189	–	–	﹤0.01%	797
2023 Q1	$721K	Sell	99,189 -19,717	-17%	-$146K	﹤0.01%	808
2022 Q4	$867K	Hold	118,906	–	–	﹤0.01%	788
2022 Q3	$919K	Buy	+118,906	New	+$1.01M	﹤0.01%	688

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ken Fisher's PNT Position: Q4 2023 in Review

Ken Fisher sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 99,189 shares — an estimated $662K sold.

Ken Fisher first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $919K in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Ken Fisher reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Ken Fisher sold 99,189 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $662K.
Ken Fisher first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Ken Fisher's POINT Biopharma Global Inc. Common Stock position peaked at $919K in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.